Project Grant P30DK144025
- The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $665,250 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, effective September 1, 2025 through June 30, 2030, will establish a Nutrition Obesity Research Centers Research Resource Center (NORC-RRC) at KUMCRI. The NORC-RRC will consist of an Administrative Core,...
- The University of Oklahoma Health Sciences Center (OUHSC) received a $107,250 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds a research project titled "NR2F2 Pioneers Neonatal Beige Adipogenesis to Protect Against Later-Life Obesity". The project investigates how exposure to high omega-6 fatty acids during early...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $773,112 Project Grant to Rockefeller University on September 5, 2025 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research to investigate the mechanisms of transcriptional control in adipocyte formation and function through nuclear receptor coactivators. The research aims to provide a better understanding of dysregulation in energy storage...
- This $168,252 federal Project Grant awarded on September 15, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research at Trustees of Boston University (DBA Boston University Medical Campus) to study the molecular mechanisms of nuclear receptor corepressors NCOR1 and SMRT and their role in regulating metabolism via actions in the intestine. The overarching goal is to expand...
- The University of Washington was awarded a $805,464 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to conduct research on the genetic and environmental contributions to obesity pathogenesis. The award, effective August 1, 2025 through April 30, 2030, will focus on using rodent models and epidemiologic/twin study approaches to: 1) test genetic risk factors for hypothalamic gliosis, and 2) test environmental risk factors for obesity and...
- This $854,803 federal Project Grant was awarded on June 13, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund the creation of a comprehensive, curated data repository for indirect calorimetry experiments in mice, which will capture critical data on factors influencing energy homeostasis, such as food intake, metabolic rate, and physical activity....
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $337,906 Project Grant to the University of Cincinnati's Sponsored Research Services division. The grant funds the "Feasibility, Acceptability, and Preliminary Phase II Efficacy Testing of a Community-Informed Infant Obesity Prevention Program Addressing the Impact of Maternal Mental Health on Eating and...
- This $2,638,760.00 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research aims to investigate a novel mechanism involving the metabolite rhodoquinone (RQ) and its potential role in improving mitochondrial function and mitigating metabolic diseases caused by obesity. Specifically, the project will elucidate how the RQ/fumarate...
- The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $222,500 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Beckman Research Institute of the City of Hope. The grant supports research to understand how conjugated bile acids regulate metabolism after bariatric surgery, with the goal of developing safer and more affordable treatments for obesity and fatty liver disease. Key activities include...
- This federal Project Grant award in the amount of $1,428,186.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), to Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Massachusetts. The project aims to investigate the role of CYP4F enzymes in regulating N-acyl amino acid signaling in humans, which has implications for understanding the early...
The Houston Nutrition Obesity Research Center (H-NORC), a joint initiative between Baylor College of Medicine and the University of Texas Health Science Center at Houston, received a $1,196,867 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to address the significant need for nutrition and obesity research in Houston and the Gulf region of Texas. The award, effective from September 10, 2025 to June 30, 2030, will enable H-NORC to establish three biomedical research cores focused on crucial aspects of nutrition and obesity research: a Clinical and Translational Obesity Research Core, a Cellular and Molecular Metabolism Core, and a Neuroendocrine Core. These research cores will support a collaborative team of 72 H-NORC members to pursue investigations in the thematic areas of pediatric and adult obesity, nutrient metabolism, and brain control of feeding behavior and metabolism, with the ultimate goal of enhancing public health.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.2m | 9/9/25 |